BACK TO MAIN  |  ONLINE BOOKSTORE  |  HOW TO ORDER

TWN Info Service on Health Issues (May14/07)
29 May 2014
Third World Network

Dear friends and colleagues,

We are pleased to share with you a report by Ms Shila Kaur, Coordinator of Health Action International (Asia-Pacific), on an important side event on antimicrobial resistance that took place on 20 May 2014 during the recent World Health Assembly.

On 24 May, health ministers attending the annual Assembly approved a resolution on “Combating antimicrobial resistance, including antibiotic resistance” that seeks to intensify efforts in this area. A global action plan will also be developed for consideration at the 2015 Assembly. There will be tripartite collaboration between the World Health Organization (WHO), the United Nations Food and Agriculture Organization (FAO) and the Organizaci๓n Mundial de Sanidad Animal (OIE – World Organization for Animal Health), with WHO taking the leadership role.

For more information on the discussion of the resolution please see TWN Health Info dated 29 May 2014: “New momentum to act against antibiotic resistance”.

With best wishes,
Third World Network


67th World Health Assembly
Side Event on Antimicrobial Resistance
Tuesday 20 May 2014
12.15 – 2.00pm

Penang, 24 May (Shila Kaur) – On the sidelines of the World Health Assembly held in Geneva on 19 – 24 May 2014, the delegations of the United Kingdom, the Netherlands, Turkey and Ghana jointly convened a side event on Antimicrobial Resistance (AMR) on Tuesday 20 May. 

Judging by the turnout – a packed conference room – the  issue is a clear hotspot for Member States.  A similar event at last year’s Assembly garnered an equally outstanding turnout.

Led by Dame Sally Davies, the Chief Medical Officer of the UK and a formidable global advocate on AMR, the four-member panel addressed national challenges and responses to AMR in Ghana, Turkey and the Netherlands.

In according her support to the seriousness of the issue, WHO’s Director General, Dr Margaret Chan made a  brief introductory address and impressed on the audience the need to move ahead quickly on tackling AMR globally.  “We are down to the last medicines for many important diseases.  Gonorrhea and syphilis are on the rise,” she stated.  “We are down to the last medicine and the pipeline for antibiotics has dried.”  She indicated that FAO, OIE (on animal health) and WHO have  jointly begun examining the animal and human dimensions of AMR.  “We do not want to be in a post-antibiotic era,” she added.  Dr Chan urged Member States to support the resolution on Antibiotics (Resolution EB135/R13) which was subsequently adopted by the WHA on 24 May as well as the Global Action Plan on AMR that will be developed in pursuance of the resolution. 

The Minister of Health of the Netherlands began her address by stating, “The bugs know no borders, they don’t discriminate and they don’t respond to drugs.”  She added that people are getting seriously ill and are dying as a result of skin infections and diarrhoea. Common surgeries like knee replacement will become potential killers because of secondary infections that are untreatable.  “This is a global problem on par with, if not more serious than, nuclear security, international terrorism and climate change,” she stressed.

In order to tackle AMR, three main areas need addressing: (i)  stopping the misuse and abuse of antibiotics; (ii)  prevention, focussing on good hygiene practices in human medicine and veterinary practice; and (iii) innovation.

Because national action is largely driven by developments at the international level, there is a need for consensus and agreement on strategies that are workable and efficient.

The Minister shared that in the Netherlands, national action has been based on, amongst other strategies, a proven ‘search and destroy’ policy on destructive bacteria such as MRSA.  In the past excessive use of antibiotics for disease prevention and to boost growth in food animals had contributed to the present alarming AMR situation.

“In 2007 the Netherlands was the world leader and heaviest user of antibiotics in food animals.  In 2009 the government agreed to decrease use of antibiotics by 50%.  In 2012, the Netherlands achieved this goal.  Resistance is now decreasing in animals.  By the end of next year, our goal is to decrease this further by 70%,” she stated.

Data from the Netherlands indicates that there are 2 million hospitalizations per year due to antibiotics resistance (ABR).  The government  therefore views hospital/healthcare acquired infections very seriously.  Interventions to tackle this situation include preventing the unnecessary use of antibiotics in both human medicine and animal husbandry.  “We have done this and it is not impossible,” said the Minister.  Wise and judicious use of antibiotics based on correct diagnosis; government-industry collaboration for research and development of new antibiotics and political courage are some of the necessary ingredients for effective intervention. 

She concluded by stating that the Netherlands will host a Ministerial meeting on AMR in June 2014 aimed at speeding up the WHO’s Global Action Plan.

In her opening remarks, the Minister of Health of Ghana, Ms. Sherry Ayittey, informed the audience that in 2012, the country experienced its first major brush with AMR when a whole hospital had to be shut down due to MRSA outbreak.  The government then initiated a national programme on ABR with the help of the Danish government, monitoring antibiotics use and AMR.  Health facilities nationwide now focus on imparting important public health messages and practices such as proper hand washing techniques; media outreach to rural women who are engaged in commercial activities, and emphasis on personal hygiene and sanitation.

Ghana’s experience indicates the need for health systems strengthening to cope with AMR.  Greater diagnostic susceptibility testing is critical.  An antibiotics surveillance unit is underway, which in partnership with a Bioequivalence Centre for drug safety and quality has  been given the mandate to achieve low levels of AMR.  Industry cooperation is being sought, putting aside profits, but focussing on reducing AMR.

According to the Minister of Health of Turkey, Mr. Mehmet Muezzinoglu, evidence based data was imperative to tackle AMR and his government recognised the need for intersectoral collaboration.  Turkey initiated an antibiotics surveillance programme in 2001;  AMR surveillance began in 2011.  Based on information gathered on the use of antibiotics, prescription practises and modalities of action, Turkey initiated a national action plan on AMR.  Currently there are regulatory measures in place; rational drug use is emphasised;  there is education of pharmacists, doctors and patients on correct antibiotics use and AMR.   Following  a review of the national action plan, a regional action plan was developed with emphasis on strengthened surveillance and data collection capacities, in close collaboration with the EU and WHO.

Dame Sally Davies shared the experience of the UK, stating emphatically that her government is committed ‘to the highest level’ in the fight against the bug.  She emphasised that currently there is insufficient data across the world on the true state of AMR; there was a critical need therefore, for countries to recognise the challenges and reduce the threats that AMR posed to public health.

The UK government recognises the importance of an across-government strategy on AMR, involving interdepartmental and cross-ministry collaborations between Ministries of Health and Agriculture, for example. 

The spread of NDM1 to 18 countries within the time period of one year had shown that there was an urgent need for global cooperation.  The situation is dire because there are no incentives for industry to ‘get the innovation pipelines right’.

“There is a public health tension in that governments wants to conserve the antibiotics that exist while the industry’s motive is to market for profit,” she stated. 

Effective surveillance systems, rapid diagnostics, appropriate vaccines and innovative approaches are the need of the day.  “If we fail, we face daunting economic consequences,” she stressed. 

In view of the following days where Member States would discuss Resolution EB 134/R13 on ABR, Dame Sally Davies urged Member States to support the Resolution and “not to make this a drafting effort but to look at it as ‘good enough’ to  move forward”.

In her end remarks, Dame Sally Davies reiterated the need for ‘obsessional sanitation and hygienic practices’ for infection control.  In an aside she observed that, “Only 1 in 3 men wash their hands after using the washroom.”  (Comparitively, more women wash their hands.)

“Wouldn’t it be good if we had new antibiotic by the year 2020?  If not, we risk going back to the pre- antibiotics era,” she concluded.

The discussion session that followed the panel presentations offered the opportunity for participants to interact freely with the panel.  Sweden shared that following concerted action on AMR in the 1990s, the country has seen a decrease in ABR statistics for all age groups; currently there is more than 70% drop in the use of antibiotics from broad spectrum to narrow spectrum antibiotics.  Since 2012, Sweden has initiated intersectoral collaboration mechanisms involving 18 agencies.

There was a suggestion from the floor to use the WHO International Health Regulations to address surveillance and monitoring weaknesses in countries.  “The existence of regulations was clearly necessary and important, however compliance was imperative,” commented the Minister of Health, Netherlands.  “It is very important that we have the doctors and pharmacists on our side,” she added.

The AMR matter must be taken to high level panels such as the post 2015 MDGs (Millennium Development Goals) and Sustainable Development Goals (Working Group).  “There is a need to ensure that heads of government negotiating the sustainable development goals are fully aware of the AMR agenda,” stated Dr Ilona Kirkbush from the Geneva Institute of Graduate Studies.  The AMR issue is an interesting example of what a global public good means, she added.  There was a need to include this in the G70 and other UN mechanisms, she reiterated.

The US Food and Drug Administration representative informed that action on AMR in the US is White House led.  Her view was that there would be no permanent victory in this area but sustained action was urgently needed with particular respect to integrated surveillance across both animal and human health sectors.  There was also a need to focus on diagnostics because “we cannot effectively treat if we do not know what we are treating.”  She impressed that that advanced science was a necessity to address AMR and vaccines.

Dame Sally Davies wrapped up by stating:

  • There is clear support for an Integrated Health agenda;
  • The Research and Development agenda was complex but must be tackled anyway;
  • It was necessary to work with the private sector but with clarity of expectations;
  • There must be ownership by Member States to handle the issue.

In his summary, Dr Keiji Fukuda, the Deputy DG for Health Security at WHO stated:

  • Awareness raising on AMR was urgently needed;
  • The  dynamics between non-communicable diseases (such as cancer) and ABR must be better understood;
  • The scope of the solution required cross-sectional involvement from the agricultural and health sectors as well civil society;
  • National action plans must be driven by political will within governments;
  • There was a need for technical and science based action with particular respect to integrated surveillance.

“From the WHO perspective, we are beginning to move on the issue; the greatest danger we face is fragmentation or action that is taken in isolation.  We must work together if we are to take this issue forward,” he concluded.

 


BACK TO MAIN  |  ONLINE BOOKSTORE  |  HOW TO ORDER